Recent studies using human induced pluripotent stem cells (iPSCs)-derived motor neurons carrying FUS mutations [39–41], and various mouse models [28, 29, 34, 37, 38, 42, 43], indicate disease-linked FUS mutations use a “gain of toxicity” mechanism to drive ALS pathogenesis. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.